Navigation Links
Will you be misdiagnosed? -- how diagnostic errors happen
Date:4/28/2008

New York, April 28, 2008 How frequently do doctors misdiagnose patients? While research has demonstrated that the great majority of medical diagnoses are correct, the answer is probably higher than patients expect and certainly higher than doctors realize. In a Supplement to the May issue of The American Journal of Medicine, a collection of articles and commentaries sheds light on the causes underlying misdiagnoses and demonstrates a nontrivial rate of diagnostic error that ranges from <5% in the perceptual specialties (pathology, radiology, dermatology) up to 10% to 15% in many other fields.

The sensitive issue of diagnostic error is rarely discussed and has been understudied. The papers in this volume confirm the extent of diagnostic errors and suggest improvement will best come by developing systems to provide physicians with better feedback on their own errors.

Guest Editors Mark L. Graber, MD, FACP (Veterans Affairs Medical Center, Northport, NY and Department of Medicine, SUNY Stony Book) and Eta S. Berner, EdD (School of Health Professions, University of Alabama at Birmingham) oversaw the development and compilation of these papers. Drs. Berner and Graber conducted an extensive literature review concerning teaching, learning, reasoning and decision making as they relate to diagnostic error and overconfidence and developed a framework for strategies to address the problem.

They write, Given that physicians overall are highly dedicated and well-intentioned, we believe that if they were more aware of these factors and their own predisposition to error, they would adopt behaviors and attitudes that would help decrease the likelihood of diagnostic error. Being confident even when in error is an inherent human trait, and physicians are no exception. The fact that most of their diagnoses are correct, and that effective feedback regarding their errors is lacking, reinforces this inclination. When directly questioned, many clinicia
'/>"/>

Contact: Pamela Poppalardo
ajmmedia@elsevier.com
212-633-3944
Elsevier Health Sciences
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
2. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
3. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
4. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
5. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
6. Salivary diagnostics, the magic mirror to your health ... at your personal computer
7. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
8. Dominion Diagnostics Announces Launch of Comprehensive New Company Website
9. PET confirmed as valuable cancer diagnostic and disease-staging tool
10. FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis
11. BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...swire/ -- Klafter & Olsen LLP has filed a,class ac...roCare" or the,"Company") (Nasdaq: ARTC ) and cer...r the Western District of Texas on behalf of all p...ArthroCare from January 24, 2008,through July 18, ...nd all,persons or entities who purchased call opti...
(Date:7/25/2008)... antiretroviral therapy may be due to genetic fact... -- A new study challenges the long-held belief th...system,s ability to restore itself after HIV patie...therapy (HAART). , From 50 percent to 90 percen...h HCV. Intravenous drug use is the main cause of b...
(Date:7/25/2008)...e/ -- BeaconEquity.com announces the,availability ...estors can view all of the daily trading notes for...oday,s Trade Alerts include: DUSA Pharmaceuticals ... Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA...(Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )....
(Date:7/25/2008)...n Significant Improvements in Members, Health, AT...leader in health,care quality management solutions...t has entered into a long-term agreement with Well...boration on Quality(SM) Incent and,Reward Best Pra...k and,primary care clinicians to promote improved ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...by Japanese government and produced by Unicef, the... Food and Agriculture// Organization, features Jac...untries and some colorful origami birds urging chi...In the advertisement shot in English at Sha Tin Ju...
...Britain and promoted by pop star Beyonce Knowles, ...ays.// All over the country, health shops are se...he shelves after pop star Beyonce Knowles said she... her latest film. The syrup, is said to be made ...
...desh to help malnourished children is yet to make ...led to aid the 5.7 million malnourished children o... age, Grassroots Features reported. Two-and-a-hal...riya tribal couple's daughter from Amolpath villag...
...iversity published his findings on a better substi...his month//. According to peer-reviewed research p...the kind of immune response doctors were looking f...ing, the vaccine was given to 100 volunteers at fo...
Other Medicine News:Health News:Scheme for Combating Malnourishment in MP Children Yet to Pick Up 2
(Date:7/22/2008)...a multi-center 293-patient European, trial -, h...ymbol: CYT, MONTREAL, July 22 /PRNewswire-FirstCa...ader in cryotherapy products to treat cardiac,arrh...resented from three,European study centers using t...ublished earlier today in the Journal of the Ameri...
(Date:7/22/2008)...s Development Initiative bring MJFF,s,current acti...nuary 20,2009, NEW YORK, July 22 /PRNewswire-USN...ry of transformative treatments and a cure for Par...r Parkinson,s Research has awarded,$2.7 million in... awards,were granted under MJFF,s Therapeutics Dev...
(Date:7/22/2008)...nd Efficacy of Treating Patients with ... and YONGIN-SI, South Korea, July 22 /PRNewswire/ ...ntario), and its South,Korean partner Green Cross ...Phase I clinical trial of its first-in-class lead ...ell-tolerated and resulted in clear,anti-cancer ef...
(Date:7/22/2008)... and Apidra(R) Resulted in Significant, Reductions... the Algorithm Us...sults from the "Adjust to,Target in Type 2 Diabete...e,Counting for Adjustment of Mealtime Insulin Glul...tes Association,s (ADA) medical journal,Diabetes ...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 1Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed Refractory CLL Who Achieve Complete Remission 1016 6TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 1TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 2TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 3TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 4TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non Hodgkins Lymphoma 1012 5Private Equity Firms Acquire American Laser Centers 7939 1Private Equity Firms Acquire American Laser Centers 7939 2Brooks and the University of Florida Reach Research Agreement 7935 1Brooks and the University of Florida Reach Research Agreement 7935 2
...merican Academy of Neurology Annual Meeting,Show A...res, BOSTON, May 01, 2007 /PRNewswire/ -- Data fro...can Academy of Neurology (AAN),meeting suggest tha...ormulation of Lamictal(R) (lamotrigine) is effecti...ilepsy with and without,secondary generalization. ...
...omen published today shows reduction of 70,percent...s, EAST HANOVER, N.J., May 02, 2007 /PRNewswire/ -...c acid) Injection significantly,reduced the incide...er three years in women with postmenopausal osteop...land Journal of Medicine,marks the first time tha...
Other Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6
Topcon offers an all-metal Trial Frame that is durably constructed, yet lightweight. It features a practical screw-thread design that extends the life of the trial frame by allowing for easy replacem
Inquire
...s the newest generation of electronic refractors. ...ws you to control the refractor from a keypad that...so controls the CP-670 Automatic Chart Projector. ...button, all the lenses are moved for you, taking y...
Uniquely designed, the wheelchair table has dual purposes. Not only does it add a modern look to any office, it is also a heavy-duty table that will support multiple instruments, and/or easily accomm
Medicine Products: